Position in MRK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$247,986,375
+$25,662,309 QoQ
Shares Held
2,061,571
-2.4% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $39,059,483,079 across 9 Drug Manufacturers - General names. MRK ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,632,647 | $22,656,369,731 | |
| 2 | ABBV |
AbbVie Inc.
|
31,254,786 | $6,797,603,407 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
27,127,533 | $3,780,764,274 | |
| 4 | AMGN |
Amgen Inc
|
6,955,345 | $2,447,238,138 | |
| 5 | JNJ |
Johnson & Johnson
|
8,739,988 | $2,136,402,666 | |
| 6 | AZN |
Astrazeneca PLC
|
4,611,176 | $909,416,130 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
2,061,571 | $247,986,375 | |
| 8 | SNY |
Sanofi
|
1,661,837 | $80,067,306 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $247,986,375 | 2,061,571 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $222,324,066 | 2,112,142 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $193,929,916 | 2,310,615 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $274,073,214 | 3,462,269 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $282,809,883 | 3,150,734 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $445,012,339 | 4,473,385 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $231,884,409 | 2,041,955 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $252,709,721 | 2,041,274 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $269,370,383 | 2,041,458 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $222,381,721 | 2,039,825 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $210,047,237 | 2,040,284 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $235,296,710 | 2,039,143 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $216,902,825 | 2,038,752 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $226,104,339 | 2,037,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $175,419,292 | 2,036,917 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $185,700,526 | 2,036,860 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $167,133,880 | 2,036,976 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $156,034,978 | 2,035,947 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $173,616,389 | 2,311,495 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $179,668,842 | 2,310,259 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $393,792,483 | 5,353,409 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $436,337,629 | 5,590,245 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $442,274,407 | 5,587,744 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $412,391,402 | 5,588,853 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $409,815,673 | 5,582,103 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||